Kapitalizacja Rynkowa Zmiana Data
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.42B 89M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 78.79B 5.01B 2026-04
Halozyme Therapeutics USD 7.91B 664M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
J&J USD 561.65B 17.5B 2026-04
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 107.27B 72.99B 2026-04
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12